
10/17/2017 – iShares NASDAQ Biotechnology ETF (IBB)
With renewed talks from the POTUS regarding drug pricing, let’s review some charts for the biotech technology sector. Specifically, I am going to analyze the charts for the iShares NASDAQ Biotechnology ETF (IBB). Are the talks coming out of the White House going to slow down any potential rebounds for the...